gen (expressed as -lo92) by enzyme-linked immunosorbent assay (37) immediately before and at the end of collagen or placebo administration. 25. Before unblinding, decisions were made concerning the analysis of five subjects (8%) that failed to complete the study. One was noncompliant and withdrew for personal reasons on day 40 after only a baseline examination. This patient was excluded from analysis and had been randomized to collagen. Four discontinued their study medication before the end of the 3-month treatment because of worsening arthritis. They were assigned the worst score in the sample for the remainder of the study and included in the analyses. All four had been randomized to placebo. One protocol violation occurred with a patient who increased the daily dose of prednisone from 5 mg to 10 mg just before month 2. Because the patient continued to do poorly and the 10-mg dose was consistent with eligibility requirements, the patient was included in the analyses; the patient had been randomized to collagen. Nuclear or whole-cell extracts prepared from human monocytes incubated with either IFN-y or IFN-a contain a protein or proteins (FcRFy) that specifically recognize the GRR in the promoter of the highaffinity immunoglobulin G Fc receptor gene (1) (2) (3) . Within the FcRFy complex is a 91-kD tyrosine-phosphorylated protein that is a component of the ISGF-3 transcription complex, which causes IFN-a-stimulated expression of early response genes (2-4). Because the peripheral blood monocyte is a critical target cell for IFN-a, IFN-y, and other cytokines, experiments were done to determine whether any cytokines other than the interferons might induce the formation of FcRFy. Whole-cell extracts were prepared from monocytes incubated with various cytokines for 15 min at 37MC and analyzed by electrophoretic mobility-shift assays (EMSAs) with a 32P-labeled oligonucleotide corresponding to the GRR ( tion of FcRF^y, whereas extracts prepared from monocytes treated with IL-3 or GM-CSF contained GRR binding complexes that migrated with a mobility different than that of the FcRFy (Fig. 1A ) complex observed after IFN--y activation. In contrast, IL-10 activated the formation of a GRR binding complex with a mobility similar to that of FcRFy. Other cytokines that have effects on monocytes-IL-1, IL-2, IL-6, tumor necrosis factor (TNF), monocyte colony-stimulating factor (M-CSF), and lipopolysaccharide-showed no formation of GRR binding complexes.
Binding of FcRFy and the complexes activated by GM-CSF treatment of monocytes was inhibited by addition of excess unlabeled GRR (Fig. 1B) , but not by addition of an unlabeled oligonucleotide corresponding to the IFN--y activation sequence (GAS) within the promoter of the guanylate-binding protein gene (Fig. 1B) (6) . The complexes induced by treatment of monocytes with IL-3 and IL-10 showed similar binding specificities (7) . When the GAS oligonucleotide was used as a probe, only IL-3, IL-5, IL-10, and GM-CSF. (A) Electrophoretic mobility-shift assays with a 32P-labeled GRR probe and whole-cell extracts. Human monocytes and basophils were purified by leukaphoresis of normal volunteers followed by Ficoll-Hypaque sedimentation and countercurrent centrifugal elutriation (1) . Monocytes were then incubated with recombinant human IFN-y (10 ng/ml; Genentech), recombinant human IL-i (100 ng/ml; Otsuka), recombinant human IL-2 (1 gg/ml; Chiron), recombinant human IL-3 (50 ng/ml; Amgen), recombinant human IL-5 (50 ng/ml; Genzyme), recombinant human IL-6 (100 U/mI; gift of G. Tosato), recombinant human IL-10 (50 ng/ml; Schering-Plough), recombinant human GM-CSF (30 ng/ml; Schering-Plough), recombinant human M-CSF (100 ng/ml; Genetics Institute), recombinant human TNF-a (10 ng/ml; Genentech), recombinant human TGF-P (10 . (B) IFN-y-(lanes 1 to 3) and GM-CSF-induced (lanes 4 to 6) GRR binding complexes formed in the presence of excess unlabeled GRR (lanes 2 and 5) or GAS (lanes 3 and 6) (6).
extracts prepared from cells treated with IFN-y or IL-10 showed the IFN-.y activation factor (GAF) transcription complex (7) . The IFN-y-induced GAF complex contains tyrosine-phosphorylated p91 (8) .
Because the GM-CSF, IL-3, and the IL-5 receptor use a common , subunit for transmembrane signal transduction (9), we determined whether IL-5 might also activate the formation of a complex that bound to the GRR. Peripheral blood basophils were treated with either IFN-y or IL-5 (Fig.  lA) . IL-5 treatment resulted in formation of a GRR binding complex that migrated more slowly than FcRFy (Fig. lA) . Unlabeled GRR, but not the GAS oligonucleotide, also competed for binding of the IL-5-inducible shift complex (7) .
The ISGF-3, GAF, and FcRFy transcription complexes contain the tyrosinephosphorylated protein p91 (2-4, 8, 10, 1 1). To determine whether the complexes induced by GM-CSF, IL-3, IL-5, or IL-10 also contained p91, we did EMSAs after treatment of extracts with an antibody to p91 (anti-p91) ( Fig. 2A) (Fig. 2B) . Other than IFN-y, only IL-10 increased expression of Fc-yRI RNA.
Therefore, only those cytokines that activate GRR binding complexes that contain p91 are capable of enhancing FcyRI RNA. Because GM-CSF and IL-3 did not induce FcyRI RNA, we pretreated monocytes with these cytokines to determine whether they might modulate IFN--y-induced FcyRI RNA. Incubation of cells with IL-3 or GM-CSF before IFN--y treatment resulted in marked inhibition of FcyRI RNA induction (Fig. 2C) . 3) , GM-CSF (lanes 4 to 6), IL-3 (lanes 7 and 8), IL-10 (lanes 9 and 10), or IL-5 (lanes 11 and 12) were incubated for 1 hour at 40C either with antiserum to the 39 COOH-terminal amino acids unique to p91 (3) (lanes 2, 5, 8, 10, 12, and 14) or antiserum to the 113-kD protein of ISGF-3 (lanes 3, 6, and 15). After incubation with the antisera (diluted 1 :100), EMSAs were done with the GRR probe. To demonstrate the specificity of the antisera, we also incubated a nuclear extract prepared from IFN-a-treated human diploid fibroblasts with the antibody (lanes 13 to 15). These extracts were then assayed for ISGF-3 formation with a 32P-labeled oligonucleotide corresponding to the IFN-stimulated response element (ISRE) of the ISG15 gene (11 Assembly of the IFN-activated transcription complexes FcRFy, ISGF-3, and GAF requires tyrosine phosphorylation and can be specifically disrupted by treatment with protein tyrosine phosphatase (PTPase) (4, 6, 11, 12) . Similar experiments were done to determine whether tyrosine phosphorylation was required for DNA binding by the complexes activated by IL-3, IL-5, IL-10, and GM-CSF. Whole cell extracts were incubated either without (at 4CC) or with the addition of purified recombinant PTPase from Yersinia enterocolitca, in the presence or absence of the PTPase inhibitor orthovanadate at 30MC for 30 min. Samples were then assayed for the presence of GRR binding complexes (Fig. 3) . The integrity of each complex was sensitive to PTPase regardless of the inducing cytokine. Vanadate inhibited the effects of the PTPase, confirming the specificity of the phosphatase toward tyrosine (Fig. 3) .
To further define which proteins within the DNA binding complexes were selectively tyrosine-phosphorylated in response to cytokine treatment, we incubated monocytes with [32Plorthophosphate for 3 hours and then with either IFN-y, GM-CSF, IL-3, or IL-10 for 15 min. Whole cell extracts were then prepared, and proteins were precipitated either with anti-p91 (Fig.  4A) or agarose beads coupled to the GRR oligonucleotide. Only extracts from monocytes treated with IFN-y or IL-10 contained 32P-labeled p91 (Fig. 4A ) (p91 migrates with an apparent molecular size of 97 kD when it is phosphorylated). A protein of 84 kD (the nature of which has not been defined) immunoprecipitated with antip91. Extracts from 32P-labeled monocytes treated with IFN-y, IL-3, or GM-CSF were incubated with the GRR-agarose beads. Affinity-purified 32P-labeled proteins were then resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) as shown in Fig. 4A . IL-3 and GM-CSF induced association of a phosphorylated protein of 80 kD with the GRR-agarose beads, whereas phosphorylated p91 was present only in extracts prepared from cells treated with IFN-y. Occasionally, a less prominent phosphorylated band of 97 kD was detected in extracts of cells treated with GM-CSF or IL-3 (Fig. 4C) . Labeling of monocytes with [35Sjmethionine and [35S~cysteine revealed that treatment with the same cytokines induced the binding of labeled proteins to the GRR of the same molecular sizes as those shown to be phosphorylated in this experiment (7) .
For confirmation that the IFN-y-or IL-10-induced phosphorylation of p91 was on tyrosine, immunoprecipitates from IFN--y-or IL-10-treated monocytes were resolved by SDS-PAGE, transferred to Immobilon membranes, and then probed with antibody to phosphotyrosine (Fig. 4B) of p91. However, the IL-10 immunoprecipitate also contained a tyrosine phosphorylated protein of 91 kD. This protein did not react with an antibody that recognized both p91 and its 84-kD spliced variant (7).
32P-labeled phosphoproteins bound to
GRR-agarose were visualized by autoradiography and then incubated with Y. enterocolitica PTPase (Fig. 4C) in the absence or presence of orthovanadate. Yersiia PTPase selectively hydrolyzed the 32P-labeled IL-3-and GM-CSF-induced 80-kD phosphoprotein, whereas incubation of identical samples in the presence of the PTPase and orthovanadate had no effect. A weaker band of 97 kD was also sensitive to PTPase treatment. These results indicated that the proteins that associated with the GRR were tyrosine phosphorylated as a result of treatment with either IL-3 or GM-CSF.
Although it seems likely that IL-3, IL-5, IL-10, or GM-CSF induce the expression of sets of early response genes that are responsible for their biological actions, no welldefined enhancers have been identified in the promoters of cellular genes that are rapidly activated by these cytokines. (4) (5) (6) and the tyrosine phosphorylation of cytoplasmic proteins (7) (8) (9) (10) . We have previously reported that the injection of EGF into mice leads to increased tyrosine phosphorylation of a number of proteins in all organs examined (11, 12) .
To detect signaling proteins that might be involved in transcriptional regulation, we isolated liver nuclei and examined them for the presence of tyrosine phosphorylated proteins before and after the administration of EGF (Fig. 1A) 1.0% Triton X-100, indicating that the protein was inside the nucleus and not a cytoplasmic contaminant or a protein associated with the outer nuclear membrane (13) . However, more than 90% of this protein could be extracted with 0.2 M NaCI (Fig. 1B) . Because the 0.2 M NaCI extraction procedure partially purified the 92-kD protein from the nucleus, the material extracted in this way was used in all subsequent protein characterizations. EGF also induced the appearance of a cytoplasmic 92-kD tyrosine phosphorylated protein (13 
